Ortho phthalaldehyde market seen reaching $5.6 billion by 2030

The ortho phthalaldehyde market is projected to grow from $4.18 billion in 2025 to $4.42 billion in 2026, then reach $5.6 billion by 2030, driven by infection control needs, more surgeries and expanding healthcare infrastructure. North America led the market in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Ortho phthalaldehyde is a high-level disinfectant used to protect medical and laboratory instruments from bacteria, viruses and mycobacteria. - Demand is rising as hospitals, labs and outpatient settings place more emphasis on infection control. - The market's growth reflects broader pressure to reduce hospital-acquired infections and improve hygiene systems.

What happened: - The Business Research Company published its Ortho Phthalaldehyde Market Report 2026, covering market size, trends and a global forecast through 2035. - The report says the market will grow from $4.18 billion in 2025 to $4.42 billion in 2026, a 5.8% annual growth rate. - The report forecasts the market will reach $5.6 billion by 2030, at a 6.1% CAGR. - The release was dated June 25, 2026. - A free sample is available here. - The full report is available here.

The details: - Ortho phthalaldehyde is effective against a broad range of microorganisms at low concentrations. - The compound is valued for fast action and chemical stability. - Prolonged exposure can cause skin or respiratory irritation. - Market growth is linked to higher awareness of hospital-acquired infections, expanding healthcare infrastructure, more surgical and diagnostic procedures, and stronger demand for high-level disinfectants. - Chemical sterilization in laboratories is also supporting demand. - Expected growth drivers through 2030 include tighter infection control rules, more preference for minimally toxic disinfectants, more outpatient surgeries, growth in biotech and diagnostic labs, and greater use of advanced hospital hygiene systems. - The report points to five product and technology trends: endoscope reprocessing, rapid-acting sterilants, automated disinfection systems, low-residue disinfectants, and stable aldehyde-based sterilization solutions. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Between the lines: - The market narrative is being driven by healthcare systems trying to prevent infections rather than just treat them after the fact. - The report's growth case leans on structural demand, not a one-time spike, because it cites aging populations, procedure volumes and lab expansion. - The regional split suggests mature demand in North America and faster adoption in Asia-Pacific. - The inclusion of forecasting dashboards and scoring tools signals that the report is aimed at commercial planning as much as market education.

What's next: - The report expects infection control regulation, surgical volume and diagnostic-lab expansion to keep supporting demand through 2030. - Growth in the elderly population should continue to increase the need for reliable disinfection in clinical settings. - The company is promoting its sales contacts and social channels alongside the report launch.

The bottom line: - Ortho phthalaldehyde remains a niche but expanding disinfectant market, with healthcare infection control and procedure growth driving the next phase of demand.